C
Catalyst OrthoScience
Early stage medical device company that is bringing the catalyst csr total shoulder to market
About Catalyst OrthoScience
Catalyst OrthoScience, founded in 2014 by orthopedic surgeon Steven Goldberg, MD, is a medical device company that has developed a novel shoulder replacement system. The company's flagship product, the Catalyst CSR™ Total Shoulder System, is engineered to make shoulder arthroplasty procedures less invasive and more efficient for surgeons.
The system is designed to enhance precision and bone preservation, aiming to provide patients with a more natural-feeling shoulder joint post-surgery. Catalyst OrthoScience targets orthopedic surgeons as its primary clients, operating within the broader orthopedic and medical device market.
The company's business model revolves around the sale of its specialized shoulder replacement systems to healthcare facilities and surgeons. Recently, the company announced it had surpassed 10,000 total shoulder arthroplasty procedures and secured an additional $20 million in financing, indicating a strong growth trajectory and market adoption.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Naples, United States
- Employees
- 53
- Open positions
- 2
- Dealroom signal
- 81.8/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Oct 2025 | $7.5M | — | Undisclosed | ↗ |
| LATE VCOther financing | Oct 2025 | $7.5M | $100M | Mutual Capital Partners · INSOUTH Bank - Member FDIC · RC Capital · Western Alliance Bank | ↗ |
Growth signals
Latest recorded traffic for Catalyst OrthoScience is 4.6K monthly website visits, up 24.3% over the last three months. Catalyst OrthoScience's team grew 6% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
IrishAngels
Series B and later4 investors entered at this stage
RC Capital
Mutual Capital Partners
Western Alliance Bank
INSOUTH Bank - Member FDIC
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Catalyst OrthoScience on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Catalyst OrthoScience’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.